The results of your health assessment have identified specific signs and symptoms that are clinically consistent with an increased risk of

• Low Secretory IgA

Secretory IgA is the predominant immunoglobulin in mucosal secretions, including the gastrointestinal tract, where it plays a critical role in maintaining mucosal immunity by neutralising pathogens and preventing microbial adhesion to the intestinal epithelium. Low levels of secretory IgA in stool indicates impaired mucosal immune function and can predispose individuals to increased susceptibility to gastrointestinal infections, imbalances and inflammation. 

If your results indicate a high likelihood of one or more of the following conditions in a chronic presentation, this may be associated with low Secretory IgA. The severity and duration of the condition often correlate with the degree of mucosal immune inefficiency

• Small Intestinal Bacterial Overgrowth

• Candidiasis 

• Helminth / Worm Infection

• Protozoal Parasitic Infection

• Biofilms 

• Gastritis, Peptic Ulcers, Reflux + GORD

• Functional Dyspepsia - H.Pylori Positive 

• Chronic bloating and abdominal discomfort

• Recurrent Diarrhoea

This investigation is optional and may be used to verify one component of an impaired gastrointestinal immune system [ Impaired GALT ]. 

It is important to note being one component of a complex system, if testing affirms healthy range of Secretory IgA, it does not rule out other components of the gastrointestinal immune network requiring support, such as 

• Faulty T cells

• B cells that don’t mature properly

• Missing M cells

Testing enables confirmation of low Secretory IgA only, as part of a large and complex network, so normal results do not discount working on the gastrointestinal tract immune network, and positive results affirm one component as a necessary requirement.